2014 Resolution on efforts to control and eliminate malaria by 2015

68th UNGA
19 Sept 2014

Analysis of precedential value

The UN Gen­eral Assem­bly (UNGA) adopted this res­o­lu­tion with­out a gen­eral vote in Sep­tem­ber 2014. The UNGA is the pre­em­i­nent gov­ern­ing body of the UN sys­tem and con­sists of all 193 UN Mem­ber States. Accord­ing to the UN press team, this res­o­lu­tion sig­nalled UNGA’s “call­ing for increased sup­port for the imple­men­ta­tion of inter­na­tional com­mit­ments and goals per­tain­ing to the fight to elim­i­nate malaria.”

Used as precedent

access to health products

Urges the inter­na­tional com­mu­nity, inter alia, to sup­port the Global Fund to Fight AIDS, Tuber­cu­lo­sis and Malaria to enable it to meet its finan­cial needs and, through coun­try-led ini­tia­tives with ade­quate inter­na­tional sup­port, to inten­sify access to afford­able, safe and effec­tive anti­malar­ial treat­ments, includ­ing artemisinin-based com­bi­na­tion ther­a­pies, inter­mit­tent pre­ven­tive ther­a­pies for preg­nant women, chil­dren under 5 and infants, ade­quate diag­nos­tic facil­i­ties, long-last­ing insec­ti­cide-treated mos­quito nets, includ­ing, where appro­pri­ate, through the free dis­tri­bu­tion of such nets and, where appro­pri­ate, to insec­ti­cides for indoor resid­ual spray­ing for malaria con­trol, tak­ing into account rel­e­vant inter­na­tional rules, includ­ing the Stock­holm Con­ven­tion on Per­sis­tent Organic Pol­lu­tants stan­dards and guide­lines.Rec­og­nizes the impor­tance of the devel­op­ment of safe and cost-effec­tive vac­cines and new med­i­cines to pre­vent and treat malaria and the need for fur­ther and accel­er­ated research, includ­ing into safe, effec­tive and high-qual­ity ther­a­pies, using rig­or­ous stan­dards, includ­ing by pro­vid­ing sup­port to the Spe­cial Pro­gramme for Research and Train­ing in Trop­i­cal Dis­eases, through effec­tive global part­ner­ships, such as the var­i­ous malaria vac­cine ini­tia­tives and the Med­i­cines for Malaria Ven­ture, where nec­es­sary stim­u­lated by new incen­tives to secure their devel­op­ment, and through effec­tive and timely sup­port for the pre-qual­i­fi­ca­tion of new anti­malar­i­als and their com­bi­na­tions.Calls upon the inter­na­tional com­mu­nity, includ­ing through exist­ing part­ner­ships, to increase invest­ment in and efforts towards research to opti­mize cur­rent tools, develop and val­i­date new, safe and afford­able malaria-related med­i­cines, prod­ucts and tech­nolo­gies, such as vac­cines, rapid diag­nos­tic tests, insec­ti­cides and their deliv­ery modes, to pre­vent and treat malaria, espe­cially for at-risk chil­dren and preg­nant women, and test­ing oppor­tu­ni­ties for inte­gra­tion in order to enhance effec­tive­ness and delay the onset of resis­tance.Reaf­firms the right to use, to the fullest extent, the pro­vi­sions con­tained in the World Trade Orga­ni­za­tion Agree­ment on Trade-Related Aspects of Intel­lec­tual Prop­erty Rights (TRIPS Agree­ment), the Doha Dec­la­ra­tion on the TRIPS Agree­ment and Pub­lic Health, the deci­sion of the Gen­eral Coun­cil of the World Trade Orga­ni­za­tion of 30 August 2003 on the imple­men­ta­tion of para­graph 6 of the Doha Dec­la­ra­tion on the TRIPS Agree­ment and Pub­lic Health, and, when for­mal accep­tance pro­ce­dures are com­pleted, the amend­ment to arti­cle 31 of the Agree­ment, which pro­vide flex­i­bil­i­ties for the pro­tec­tion of pub­lic health, and in par­tic­u­lar to pro­mote access to med­i­cines for all and to encour­age the pro­vi­sion of assis­tance to devel­op­ing coun­tries in this regard, and calls for the broad and timely accep­tance of the amend­ment to arti­cle 31 of the Agree­ment, as pro­posed by the Gen­eral Coun­cil of the World Trade Orga­ni­za­tion in its deci­sion of 6 Decem­ber 2005.

universal health coverage

Requests rel­e­vant inter­na­tional orga­ni­za­tions, in par­tic­u­lar the World Health Orga­ni­za­tion and the United Nations Chil­dren’s Fund, to assist the efforts of national Gov­ern­ments to pro­vide uni­ver­sal access to malaria con­trol inter­ven­tions to address all at-risk pop­u­la­tions, in par­tic­u­lar young chil­dren and preg­nant women, in malaria-endemic coun­tries, par­tic­u­larly in Africa, as rapidly as pos­si­ble, with due regard to ensur­ing the proper use of those inter­ven­tions, includ­ing long-last­ing insec­ti­cide-treated nets, and sus­tain­abil­ity through full com­mu­nity par­tic­i­pa­tion and imple­men­ta­tion through the health sys­tem.